Type I interferonopathies, such as the monogenic disease Aicardi-Goutières syndrome (AGS), often involve chronic systemic and neurological autoinflammation and high levels of type I interferon (IFN) activity in the blood and cerebrospinal fluid (Crow and Stetson, 2022). Here, IFNA1 is linked to Aicardi-Goutieres syndrome.